Market revenue in 2023 | USD 470.0 million |
Market revenue in 2030 | USD 759.9 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Otc rdt |
Fastest growing segment | OTC RDT |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC RDT, Professional RDT |
Key market players worldwide | ACON Laboratories, Abbott Laboratories, BD, BioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, Cardinal Health Inc, Creative Diagnostics, Roche, McKesson Corp, Meridian Bioscience, Trinity Biotech PLC ADR, Zoetis Inc Class A, Artron Bioresearch, Alfa Medical Group, BioNTech SE ADR, Sight Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rapid medical diagnostic kits market will help companies and investors design strategic landscapes.
Otc rdt was the largest segment with a revenue share of 62.77% in 2023. Horizon Databook has segmented the Spain rapid medical diagnostic kits market based on otc rdt, professional rdt covering the revenue growth of each sub-segment from 2018 to 2030.
According to Worldometer, as of June 10, 2020, there were around 289,360 confirmed cases of COVID19 in Spain and around 27,136 deaths occurred due to the disease. The pandemic has created huge demand for rapid tests in the country, as the government is focused on mass testing to control the spread of the virus.
Furthermore, increasing prevalence of infectious diseases is anticipated to boost market growth during the forecast period. According to a report published by the Institute of Health Metrics and Evaluation, there were about 418,516 deaths recorded in Spain in 2016.
Overall, noncommunicable diseases were reported to be the highest cause for death in Spain, leading to an estimated 388,617 deaths. Also, according to the International Diabetes Federation, about 3,584,500 were estimated during 2017 and the prevalence was estimated to be 10.4%.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain rapid medical diagnostic kits market , including forecasts for subscribers. This country databook contains high-level insights into Spain rapid medical diagnostic kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account